Heron Therapeutics
Jason Chu is an experienced financial professional who has worked in various roles at companies in the pharmaceutical industry such as Heron Therapeutics, Alnylam Pharmaceuticals, ARIAD Pharmaceuticals, Infinity Pharmaceuticals, Onyx Pharmaceuticals, and Amgen. With a background in transfer pricing at Ernst & Young, Jason's expertise lies in financial planning and analysis, business planning, commercial finance, and global markets finance. Jason holds an MBA from UCLA Anderson School of Management and a BA in Economics from Trinity College-Hartford.